Heather A. Wakelee, MD, FASCO brings over 20 years of clinical experience specializing in the treatment of lung cancer, thymoma, and mesothelioma. Currently she serves as Deputy Director of the Stanford Cancer Institute and is the Division Chief of Medical Oncology. She is the President of the International Association for the Study of Lung Cancer (IASLC) and is active in several national and international organizations related to lung cancer and thymoma. Previously as physician lead for the thoracic malignancies clinical research group at Standford, she developed research programs related to lung cancer and thymoma across clinical trials, translation work and population sciences. She is the Principal Investigator on numerous clinical trials and has held advisory board roles with Genentech/Roche, Janssen, Daiichi Sankyo, and Mirati. Dr. Wakelee is a board-certified physician in internal medicine and medical oncology. She completed a fellowship in oncology and a residency in internal medicine at Stanford University. She holds a medical degree from Johns Hopkins University, and a Bachelor of Arts from Princeton University in Molecular Biology.